ANDA 76799, held by Alphapharm. Pioglitazone Hydrochloride.
As of Nov 16, 2026, ANDA 76799 (Pioglitazone), held by Alphapharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 15, 2005 | Original application | Tentative approval | None posted |
| Pioglitazone15MG · tablet; oral | Pioglitazone Hydrochloride | None (tentative approval) |
| Pioglitazone30MG · tablet; oral | Pioglitazone Hydrochloride | None (tentative approval) |
| Pioglitazone45MG · tablet; oral | Pioglitazone Hydrochloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters